Australia terminates University of Queensland vaccine deal with CSL after false positives for HIV

Scott Morrison says University of Queensland coronavirus vaccine will not be able to proceed'

The Australian government has terminated its agreement with Australian biotech company CSL Limited to supply 51m doses of a Covid-19 vaccine being developed by the University of Queensland, after vaccine trial participants returned false positive test results for HIV.

Australia had hoped the protein vaccine would be available by mid-2021. Phase one clinical trials in humans began in July in Brisbane, with phase two and three clinical trials due to commence in December. It is one of four vaccines secured by the Australian government.